Depyrogenated Sterile Empty Vials Market size to exceed $8bn by 2025

Depyrogenated Sterile Empty Vials Market size is set to exceed USD 8 billion by 2025; according to a new research report by Global Market Insights, Inc.

Government schemes to support the development of innovative packaging of various pharmaceutical products is a key factor driving depyrogenated sterile empty vials market growth. Additionally, the government policies aims on improvement in packaging quality for efficient storage and medical training. Thereby, policies offered by government and other organizations will further accelerate the business growth over the coming years. For instance, focus of Indian government on Pharma Vision 2020 aims to make India an universal leader in end to end drug manufacturing. Additionally, in order to boost investments the approval time for new facilities has been decreased. Moreover, increasing funding by government organizations to numerous pharmaceutical companies along with investments in R&D for development of innovative products and robust infrastructure proves beneficial for business growth.  


Request Sample Buy NowInquiry Before Buying


Increasing incidence of infectious diseases globally will boost depyrogenated sterile empty vials industry growth. According WHO data published on July 2018, nearly 36.9 million people were living with HIV at the end of 2017 with worldwide 1.8 million individuals that were newly infected in 2017. Rising number of HIV cases augments demand for depyrogenated sterile empty vials for sufficient sample storage thereby accelerating the business growth. Furthermore, increasing number of diagnostic tests in clinical and research labs will foster the depyrogenated sterile empty vials industry growth. However, surging demand for other parenteral packaging alternatives for depyrogenated sterile empty vials may hamper the business growth.

U.S. Depyrogenated Sterile Empty Vials Market, By Product, 2018 & 2025 (USD Million)
Depyrogenated Sterile Empty Vials Market

Get more details on this report - Request Free Sample PDF

More than 20 ml product segment was valued more than USD 1.5 million in 2018 and will witness tremendous growth in foreseeable future. These vials are ideal for storing samples and are extensively used for packaging of injectables. Additionally, maximum number of clinical studies leads to increased number of injectables that further augments industry growth.

Clinical labs segment held considerable revenue in 2018 and is anticipated to witness around 4% CAGR during the analysis timeframe. Increasing demand and usage of depyrogenated vials in clinical lab settings for efficient sample storage propels segmental growth. Moreover, growing awareness regarding early disease diagnosis further stimulates the segmental growth.

Browse key industry insights spread across 165 pages with 126 market data tables & 7 figures & charts from the report, “Depyrogenated Sterile Empty Vials Market Size By Product (2 ml, 5 ml, 10 ml, 20 ml, More than 20 ml), By End-use (Clinical Labs, Compounding Labs, Pharmaceutical Manufacturers), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, Netherlands, China, Japan, India, Australia, Brazil, Mexico, Saudi Arabia, South Africa, UAE), Application Potential, Competitive Market Share & Forecast, 2019 – 2025” in detail along with the table of contents:

Asia Pacific depyrogenated sterile empty vials market accounted for around 24% revenue share in 2018 and is estimated to witness momentous growth over the forecast period. Industry players in this region are focusing to invest in R&D to launch innovative products in the market that is expected to boost regional growth over the coming years. Furthermore, increasing prevalence of infectious diseases further drives the Asia Pacific depyrogenated sterile empty vials business growth.

Eminent industry players operating in depyrogenated sterile empty vials market include APG Pharma, Corning Incorporated, DWK Life Sciences, Gerresheimer, Merck, NIPRO, Radpharm Scientific, SGD Pharma, Stevanato, SCHOTT, Thermo Fisher Scientific and VWR International. Numerous business players aim towards initiating new product launch to sustain in market with financial stability. For instance, in April 2019, SCHOTT collaborated with SINCAD a French engineering firm. This collaboration aimed at high quality pharmaceutical packaging. SCHOTT relies on advanced camera systems to ensure quality of each product. Such strategies ensures high quality pharmaceutical packaging and enhances product portfolio of the firm.

Inquiry Before BuyingRequest Sample

Depyrogenated sterile empty vials market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2014 to 2025, for the following segments:

Depyrogenated Sterile Empty Vials Market By Product, 2014-2025 (USD Million)

  • 2 ml
  • 5 ml
  • 10 ml
  • 20 ml
  • More than 20 ml

 Depyrogenated Sterile Empty Vials Market By End-use, 2014-2025 (USD Million)

  • Clinical Labs
  • Compounding Labs
  • Pharmaceutical Manufacturers
  • Others

 The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Netherlands
  • Asia Pacific
    • China
    • Australia
    • Japan
    • India
  • Latin America
    • Brazil
    • Mexico
  • Middle East Asia & Africa
    • Saudi Arabia
    • South Africa
    • UAE


We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X